Skip to main content
. 2018 Sep 28;5(2):HEP08. doi: 10.2217/hep-2018-0002

Figure 1. . Classification of available hepatocellular carcinoma therapies based on the stages of patients.

Figure 1. 

Curative therapies are suitable for early stage patients and includes surgical resection, liver transplantation, and local ablative therapies. Physical ablation can be by done any energy source, which works by heating (radiofrequency, microwave, and laser) or cooling (cryo/freeze–thaw) of tumor affected area. Palliative therapies includes embolizing, systemic and molecular targeted therapies.

CPT: Cisplatin; DXR: Doxorubicin; HCC: Hepatocellular carcinoma; MMC: Mitomycin C; PEI: Percutaneous ethanol injection; PIAF: Cisplatin, interferon, adriamycin, and fluorouracil.